Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to:
1. Evaluate how the body reacts to sorafenib when taken daily in combination with
paclitaxel and carboplatin,
2. Measure the blood levels of sorafenib, paclitaxel and carboplatin at specific times
after taking the medication, and
3. To determine the safety of sorafenib.